No association of the polyhistidine tract polymorphism of the ZIC2 gene with neural tube defects in a South American (ECLAMC) population

Molecular Medicine Reports

Volumn 1, Issue 3, 2008, Pages 443-446

  Costa Lima, Marcelo A ^a,b   Meneses, Heloisa N M ^a   El Jaick, Kenia B ^a,c   Amorim, Márcia R ^a   Castilla, Eduardo E ^d,e   Orioli, Iêda Maria ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e CEMIC   (Argentina)

Author keywords

Latin American Collaborative Study of Congenital Malformations; Neural tube defect; Polyhistidine tract; ZIC2

Indexed keywords

POLYHISTIDINE;

ALLELE; ARTICLE; CONTROLLED STUDY; ENCEPHALOCELE; FAMILY; FATHER; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOLOPROSENCEPHALY; HOMOZYGOSITY; HUMAN; LOGLINEAR MODEL; MAJOR CLINICAL STUDY; MALE; MICROPHTHALMIA; MOTHER; NEURAL TUBE DEFECT; NEWBORN; SAMPLING; SOUTH AMERICA; ZIC2 GENE;

MUS;

EID: 69249091367     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.3.443     Document Type: Article

References (20)

1. Elwood JM, Little J and Elwood JH: Epidemiology and Control of Neural Tube Defects. Oxford University Press, Oxford, pp96-167, 1992.
2. Juriloff DM and Harris MJ: Mouse models for neural tube closure defects. Hum Mol Genet 9: 993-1000, 2000. (Pubitemid 30216111)
3. Brown S, Russo J, Chitayat D and Warburton D: The 13q-syndrome: the molecular definition of a critical deletion region in band 13q32. Am J Hum Genet 57: 859-866, 1995.
4. Nagai T, Aruga J, Minowa O, Sugimoto T, Ohno Y, Noda T and Mikoshiba K: Zic2 regulates the kinetic of neurulation. Proc Natl Acad Sci USA 97: 1618-1623, 2000.
5. Brown SA, Warburton D, Brown LY, Yu C, Roeder ER, Stengel-Rutkowski S, Hennekam RCM and Muenke M: Holoprosencephaly due to mutations in ZIC2, a homologue of Drosophila odd-paired. Nat Genet 20: 180-183, 1998.
6. Brown LY, Odent S, David V, Blayau M, Dubourg C, Apacik C, Delgado MA, Hall BD, Reynolds JF, Sommer A, Wieczorek D, Brown SA and Muenke M: Holoprosencephaly due to mutations in ZIC2: alanine tract expansion mutations may be caused by parental somatic recombination. Hum Mol Genet 10: 791-796, 2001. (Pubitemid 32331589)
7. Lowry RB: Holoprosencephaly. Am J Dis Child 128: 887, 1974.
8. Roach E, Demyer W, Conneally PM, Palmer C and Merritt AD: Holoprosencephaly: birth data, genetic and demographic analyses of 30 families. Birth Defects Orig Artic Ser 11: 294-313, 1975.
9. Brown LY, Hodge SE, Johnson WG, Guy SG, Nye JS and Brown S: Possible association of NTD with a polyhistidine tract polymorphism in the ZIC2 gene. Am J Med Genet 108: 128-131, 2002.
10. Klootwijk R, Groenen P, Schijvenaars M, Hol F, Hamel B, Straatman H, Steegers-Theunissen R, Mariman E and Franke B: Genetic variants in ZIC1, ZIC2, and ZIC3 are not major risk factors for neural tube defects in humans. Am J Med Genet A 124: 40-47, 2004. (Pubitemid 38139814)
11. Lazaro L, Dubourg C, Pasquier L, Le Duff F, Blayau M, Durou MR, De la Pintierre AT, Aquiella C, David V and Odent S: Phenotypic and molecular variability of the holoprosencephalic spectrum. Am J Med Genet A 129: 21-24, 2004. (Pubitemid 38989038)
12. Zhu H, Junker WM, Finnell RH, Brown S, Shaw GM, Lammer EJ, Canfield M and Hendricks K: Lack of association between ZIC2 and ZIC3 genes and the risk of neural tube defects (NTDs) in Hispanic populations. Am J Med Genet A 116: 414-415, 2003. (Pubitemid 37063604)
13. Castilla EE and Orioli IM: ECLAMC: The Latin-American Collaborative Study of Congenital Malformations. Community Genet 7: 76-94, 2004.
14. Nazer J, Lopez-Camelo J and Castilla EE: ECLAMC: 30-year study of epidemiological surveillance of neural tube defects in Chile and Latin-America. Rev Med Chil 129: 531-539, 2001. (Pubitemid 33679634)
15. Spielman RS, McGinnis RE and Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52: 506-516, 1993. (Pubitemid 23311321)
16. Weinberg CR: Methods for detection of parent-of-origin effects in genetic studies of case-parent triads. Am J Hum Genet 65: 229-235, 1999. (Pubitemid 30470468)
17. Dubourg C, L Lazaro L, Pasquier L, Bendavid C, Blayau M, Le Duff F, Durou MR, Odent S and David V: Molecular screening of SHH, ZIC2, SIX3, and TGIF genes in patients with features of holoprosencephaly spectrum: mutation review and genotype-phenotype correlations. Hum Mutat 24: 43-51, 2004. (Pubitemid 38859223)
18. Yamanoshita O, Kubota T, Hou J, Ping YM, Zhang XL, Li XP, Li SS, Li XX, Zhu DC, Fukushima Y and Nakajima T: DHPLC is superior to SSCP in screening p53 mutations in esophageal cancer tissues. Int J Cancer 114: 74-79, 2005. (Pubitemid 40194310)
19. Orioli IM and Castilla EE: Clinical epidemiologic study of holoprosencephaly in South America. Am J Med Genet A 143: 3088-3099, 2007. (Pubitemid 350274823)
20. Cohen MM Jr: Perspectives on holoprosencephaly: Part I. Epidemiology, genetics, and syndromology. Teratology 40: 211-235, 1989.